Who are Biolumen's investors?

Biolumen's investors include Embryo Ventures.

How much funding has Biolumen raised?

Biolumen has disclosed $250K raised across 1 round.

Where is Biolumen headquartered?

Biolumen is headquartered in San Francisco, US.

Biolumen

San Francisco, US · Founded 2019 · Delaware corporation · 1 known investors

Biolumen is a biotech company focused on bioengineering for wellness, founded by a serial entrepreneur with expertise in biopolymers. The company appears to be developing food and beverage-related products leveraging bioengineering innovations.

Biotech FoodTech Wellness & Fitness

Founders & leadership

Paolo CostaSecretary

Gabriel PaulinoPresident and Chief Executive Officer

Stefan PinterTreasurer

Investors · 1

Embryo VenturesLondon

Reported raises · per SEC filings

Form D private placements

$250K disclosed across 1 round · 2019

▶$250KraisedNov 2019 · 1 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Paolo CostaExecutive Officer, Director, Promoter
Gabriel PaulinoExecutive Officer, Director, Promoter
Stefan PinterExecutive Officer, Director

Offering amount: $250K
Amount sold: $250K
First sale: Oct 2019
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Lumen4 shared keywordsLumen develops orally-delivered biologic drugs using genetically engineered spirulina algae, which expresses therapeutic proteins such as enzymes, antibodies, and cytokines that are spray-dried into shelf-stable powders and capsules. Its pipeline targets conditions including weight loss, C. difficile, Crohn's disease, ulcerative colitis, and respiratory infections.

Morelumen3 shared keywordsLumen makes lightly carbonated, dairy-free protein beverages containing 16g of clear, fast-absorbing collagen and grass-fed protein along with organic ingredients, omega-3s, and adaptogens. The drinks are sold direct to consumers on a subscription basis and positioned for daily wellness, recovery, and hydration.

SOSV Visit SOSV3 shared keywordsSOSV is a deep tech venture capital firm that makes pre-seed investments (up to $550k) in about 60 startups per year and joins follow-on rounds, backing founders in biotech, therapeutics, climate, energy, and physical AI. It operates labs and offices in San Francisco, New York City, and Newark, with additional teams in India, China, and the EU.

EquityZen3 shared keywordsEquityZen operates an online marketplace that gives accredited individual investors access to shares in late-stage private companies through secondary market transactions. Now part of Morgan Stanley, the platform provides private market data, offering documents, and guided investment processes for buying and selling pre-IPO equity.

Companies competing with Biolumen for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Biolumen do?: Biolumen is a biotech company focused on bioengineering for wellness, founded by a serial entrepreneur with expertise in biopolymers. The company appears to be developing food and beverage-related products leveraging bioengineering innovations.
Who are Biolumen's investors?: Biolumen's investors include Embryo Ventures.
How much funding has Biolumen raised?: Biolumen has disclosed $250K raised across 1 round.
Where is Biolumen headquartered?: Biolumen is headquartered in San Francisco, US.